dysprosium has been researched along with ferric hydroxide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shortkroff, S; Sledge, CB; Venkatesan, P; Zuckerman, JD | 2 |
| Anderson, RJ; Atcher, RW; Hurson, BJ; Lankenner, PA; Lionberger, DR; Rose, HA; Shortkroff, S; Sledge, CB; Zalutsky, MR; Zuckerman, JD | 1 |
| Shortkroff, S; Sledge, CB; Vella, M; Venkatesan, P; Zuckerman, JD | 1 |
| Barrett, WP; Shortkroff, S; Sledge, CB; Snyder, MA; Venkatesan, P; Zalutsky, MR; Zuckerman, JD | 1 |
| Adelstein, SJ; English, RJ; Shortkroff, S; Sledge, CB; Venkatesan, PP; Zalutsky, MR | 1 |
| Doepel, LK | 1 |
| Barnes, CL; Shortkroff, S; Sledge, CB; Wilson, M | 1 |
| Angelberger, P; Flores, J; Graninger, W; Havlik, E; Kvaternik, H; Pesau, B; Pirich, C; Sinzinger, H; Wanivenhaus, A | 1 |
| Aiginger, J; Angelberger, P; Flores, J; Havlik, E; Kvaternik, H; Pirich, C; Prüfert, U; Schwarmeis, E; Sinzinger, H; Wanivenhaus, A | 1 |
| Angelberger, P; Flores, JA; Germadnik, D; Havlik, E; Kvaternik, H; Lang, S; Pilger, A; Pirich, C; Prüfert, U; Rüdiger, HW; Schwameis, E; Sinzinger, H; Wanivenhaus, A | 1 |
| Havlik, E; Hefner, A; Karanikas, G; Pirich, C; Preitfellner, J; Schaffarich, P; Sinzinger, H | 1 |
1 trial(s) available for dysprosium and ferric hydroxide
| Article | Year |
|---|---|
Intra-articular radiation treatment of rheumatoid synovitis of the ankle with dysprosium-165 ferric hydroxide macroaggregates.
Topics: Adult; Aged; Ankle Joint; Arthritis, Rheumatoid; Dysprosium; Female; Ferric Compounds; Humans; Male; Middle Aged; Radioisotopes; Synovitis; Treatment Outcome | 1994 |
11 other study(ies) available for dysprosium and ferric hydroxide
| Article | Year |
|---|---|
Treatment of antigen-induced arthritis in rabbits with dysprosium-165-ferric hydroxide macroaggregates.
Topics: Animals; Antigens; Arthritis; Arthritis, Experimental; Brachytherapy; Cartilage, Articular; Drug Carriers; Dysprosium; Ferric Compounds; Fibrosis; Hyperplasia; Knee Joint; Ovalbumin; Particle Size; Rabbits; Radiography; Radioisotopes; Synovial Membrane | 1989 |
Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dysprosium; Evaluation Studies as Topic; Female; Ferric Compounds; Follow-Up Studies; Half-Life; Humans; Injections, Intra-Articular; Iron; Knee Joint; Liver; Lymph Nodes; Male; Middle Aged; Pilot Projects; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Sodium Pertechnetate Tc 99m; Synovitis; Time Factors | 1986 |
Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dysprosium; Evaluation Studies as Topic; Ferric Compounds; Follow-Up Studies; Humans; Injections, Intra-Articular; Knee Joint; Middle Aged; Pain; Radioisotopes; Recurrence; Synovial Membrane; Veins | 1988 |
Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-ferric hydroxide macroaggregates.
Topics: Adult; Aged; Arthritis, Rheumatoid; Dysprosium; Female; Ferric Compounds; Follow-Up Studies; Humans; Knee Joint; Male; Middle Aged; Radioisotopes; Radiotherapy Dosage; Synovial Membrane | 1987 |
Treatment of rheumatoid arthritis using radiopharmaceuticals.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Dysprosium; Female; Ferric Compounds; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Synovial Membrane | 1987 |
Radiation synovectomy with 165Dy-FHMA: lymph node uptake and radiation dosimetry calculations.
Topics: Arthritis, Rheumatoid; Dysprosium; Female; Ferric Compounds; Half-Life; Humans; Iron; Knee Joint; Liver; Lymph Nodes; Models, Anatomic; Ovary; Radiometry; Radiotherapy Dosage; Synovial Membrane; Time Factors | 1986 |
From the NIH. Radionuclide therapy for arthritic knees.
Topics: Arthritis, Rheumatoid; Dysprosium; Ferric Compounds; Humans; Knee Joint; Radioisotopes; Synovial Membrane | 1985 |
[Radiosynovectomy with dysprosium-165 iron hydroxide].
Topics: Animals; Arthritis, Rheumatoid; Dysprosium; Female; Ferric Compounds; Half-Life; Humans; Male; Rabbits; Radiation Dosage; Radioisotopes; Rats; Synovial Membrane; Tissue Distribution | 1993 |
Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter.
Topics: Adult; Dysprosium; Female; Ferric Compounds; Gamma Cameras; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Radioisotopes; Synovial Membrane; Synovitis; Tissue Distribution; Whole-Body Counting | 1997 |
Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Arthritis; Biomarkers, Tumor; Deoxyguanosine; DNA Damage; Dysprosium; Female; Ferric Compounds; Humans; Immunoglobulins; Knee Joint; Male; Radioisotopes; Radionuclide Imaging; Synovitis; Technetium | 2000 |
Radiation exposure from patients treated with 165Dy-ferric hydroxide.
Topics: Algorithms; Dysprosium; Ferric Compounds; Fingers; Half-Life; Health Occupations; Humans; Occupational Exposure; Radiometry; Radiopharmaceuticals | 2001 |